ACM
ANVS icon

AIGH Capital Management’s Annovis Bio ANVS Stock Holding History

AIGH Capital Management’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-48,941
Closed -$464K – 42
2023
Q3 		$464K Sell
48,941
-370,129
-88% -$4.58M 0.22% 44
2023
Q2 		$5.99M Buy
+419,070
New +$5.93M 2.44% 12
2021
Q4 		– Sell
-66,469
Closed -$2.11M – 53
2021
Q3 		$2.11M Sell
66,469
-60,000
-47% -$3.45M 0.44% 42
2021
Q2 		$10.8M Buy
126,469
+9,213
+8% +$426K 1.95% 15
2021
Q1 		$3.1M Sell
117,256
-346,541
-75% -$7.41M 0.65% 34
2020
Q4 		$3.5M Buy
+463,797
New +$2.51M 1.42% 21

Other funds holding ANVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WFAG
Wescott Financial Advisory Group Philadelphia, Pennsylvania $1.29B AUM 21.04% 1-Year Est. Return
SIAP
Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $599M AUM 28.66% 1-Year Est. Return
RAM
Redmond Asset Management Henrico, Virginia $401M AUM 14.95% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
MWM
Modera Wealth Management Westwood, New Jersey $9.37B AUM 23.82% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

AIGH Capital Management's ANVS Position: Q4 2023 in Review

AIGH Capital Management sold out of Annovis Bio (ANVS) in Q4 2023, closing a stake of 48,941 shares — an estimated $464K sold.

AIGH Capital Management first reported a position in ANVS in Q4 2020 and held it in 6 quarters. The position peaked at $10.8M in Q2 2021. 36 funds tracked by Wall St. Rank hold ANVS as of Q4 2023.

  • AIGH Capital Management reported no remaining Annovis Bio position as of Q4 2023 after selling out during the quarter.
  • AIGH Capital Management sold 48,941 Annovis Bio shares in Q4 2023, an estimated $464K.
  • AIGH Capital Management first reported a position in Annovis Bio in Q4 2020 and held it in 6 quarters.
  • AIGH Capital Management's Annovis Bio position peaked at $10.8M in Q2 2021.
  • 36 funds tracked by Wall St. Rank held Annovis Bio as of Q4 2023.

Based on AIGH Capital Management's 13F filing for Q4 2023, filed 12 Feb 2024.